Sanyal, Arun J.

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD

Linge, J., Nasr, P., Sanyal, A. J., Dahlqvist Leinhard, O., & Ekstedt, M. (2023) · JHEP Reports

Liver Disease Diagnosis and TreatmentNutrition and Health in Aging

Cited by 42

The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease

Puri, P., & Sanyal, A. J. (2018) · Clinics in Liver Disease

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 33

Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis

Shi, H., Wang, X., Sloas, C., Gerlach, B., Yurdagul, A., Moore, M. P., Jung, E. J., Mirshahi, F., Ronzoni, L., Sanyal, A. J., et al. (2025) · Science Translational Medicine

Phagocytosis and Immune RegulationLiver Disease Diagnosis and Treatment

Cited by 30

Modeling the health and economic impact of pharmacologic therapies for MASLD in the United States

Wallace, C., Gamkrelidze, I., Estes, C., Razavi, H., & Sanyal, A. J. (2025) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentHealth Systems, Economic Evaluations, Quality of Life

Cited by 27

Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date

Albhaisi, S., & Sanyal, A. J. (2019) · Pharmaceutical Medicine

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 27

Design of a multicenter randomized clinical trial for treatment of alcohol-associated hepatitis

Tu, W., Gawrieh, S., Dasarathy, S., Mitchell, M. C., Simonetto, D. A., Patidar, K. R., McClain, C. J., Bataller, R., Szabo, G., Tang, Q., et al. (2023) · Contemporary Clinical Trials Communications

Alcohol Consumption and Health EffectsLiver Disease and Transplantation

Cited by 21

WED-263 A machine learning approach to identify patient features associated with metabolic dysfunction-associated steatohepatitis from the United Kingdom biobank

Schattenberg, J. M., Gastaldelli, A., Malhi, H., Allen, A. M., Noureddin, M., Karamchandani, U., Romero, J., Henstock, P., Emir, B., & Sanyal, A. J. (2024) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentArtificial Intelligence in Healthcare

Cited by 1

TOP-289 Artificial intelligence-based measurement of non-alcoholic steatohepatitis is an accurate tool for clinical trial enrollment and end point assessment

Pulaski, H., Hou, H., Resnick, M., Harrison, S. A., Sanyal, A. J., Ratziu, V., Burt, A., Bedossa, P., Montalto, M., & Wack, K. (2024) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentArtificial Intelligence in Healthcare and Education

Cited by 1